Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.89 USD | +2.23% | +6.74% | +59.73% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 181M | Sales 2025 * | 249M | Capitalization | 633M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | 21M | EV / Sales 2024 * | 3.49 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.55 x |
P/E ratio 2024 * |
-32.9
x | P/E ratio 2025 * |
31.8
x | Employees | 315 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.92% |
Latest transcript on Harrow, Inc.
1 day | +2.23% | ||
1 week | +6.74% | ||
Current month | +75.56% | ||
1 month | +69.90% | ||
3 months | +58.74% | ||
6 months | +90.72% | ||
Current year | +59.73% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Andrew Boll
DFI | Director of Finance/CFO | 41 | 11-11-30 |
Jamie Webb
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Director/Board Member | 65 | Jan. 25 | |
Adrienne Graves
BRD | Director/Board Member | 69 | Jan. 25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 17.89 | +2.23% | 249,439 |
24-05-23 | 17.5 | +1.63% | 545,275 |
24-05-22 | 17.22 | +4.43% | 341,050 |
24-05-21 | 16.49 | -1.79% | 279,299 |
24-05-20 | 16.79 | +0.18% | 332,819 |
Delayed Quote OTC Markets, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.73% | 633M | |
+38.51% | 727B | |
+32.55% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.20% | 205B | |
-5.73% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- HROW Stock